C000198378 Performance — iShares Evolved U.S. Innovative Healthcare ETF
Data updated: 2022-10-12
C000198378 returned −4.25% over one year to Jul 2022. The annualised 3-year return is +13.79%. The fund beat its Money Market category average: $100 invested three years ago grew to $147, against $108 for the category, and to $96 over one year, against $91. Volatility over the past three years was 15.03% a year. In the 12 months to Jul 2022 the fund took in a net $898K, and assets reached $36.79M.
C000198378 Growth of $100
What $100 invested in iShares Evolved U.S. Innovative Healthcare ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Money Market category average over the same months.
| Period | C000198378 | Category average |
|---|---|---|
| 1 year (Aug 2021 – Jul 2022) | $96 | $91 |
| 3 years (Aug 2019 – Jul 2022) | $147 | $108 |
C000198378 Trailing Returns
Total returns to Jul 2022, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | −4.25% |
| 3 years (annualised) | +13.79% |
C000198378 Annual Returns
Calendar-year total returns of iShares Evolved U.S. Innovative Healthcare ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2022 (Jan–Jul) | −5.06% |
| 2021 | +12.35% |
| 2020 | +19.15% |
| 2019 (Aug–Dec) | +15.94% |
C000198378 Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | −6.5% | −2.6% | +6.4% | −5.3% | +1.1% | +1.0% | +1.4% | — | — | — | — | — |
| 2021 | +4.0% | −2.4% | −1.4% | +2.4% | +0.2% | +6.0% | +2.4% | +3.9% | −5.4% | +1.2% | −2.4% | +3.9% |
| 2020 | −3.1% | −2.5% | −3.8% | +12.2% | +5.1% | +0.4% | +0.4% | +1.6% | −0.7% | −4.3% | +10.0% | +3.8% |
| 2019 | — | — | — | — | — | — | — | −0.8% | −0.9% | +6.6% | +7.1% | +3.4% |
C000198378 Risk
Risk measures from monthly returns over Aug 2019 – Jul 2022.
- 3-year volatility (annualised): 15.03%
- 3-year Sharpe ratio: 0.62 (vs 4.5% risk-free rate)
- Best month: +12.21% (Apr 2020)
- Worst month: −6.48% (Jan 2022)
C000198378 Fund Flows
Monthly money in and out of iShares Evolved U.S. Innovative Healthcare ETF, from SEC Form N-PORT.
- 12-month net flow: $898K
- 12-month gross sales (incl. reinvestments): $10.5M
- Sales ÷ redemptions: 1.09×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2022 | $0 | $0 | $0 |
| Jun 2022 | $0 | $0 | $0 |
| May 2022 | $1.7M | $0 | $1.7M |
| Apr 2022 | $1.7M | $0 | $1.7M |
| Mar 2022 | $3.5M | $8.0M | −$4.6M |
| Feb 2022 | $0 | $1.6M | −$1.6M |
| Jan 2022 | $0 | $0 | $0 |
| Dec 2021 | $0 | $0 | $0 |
| Nov 2021 | $0 | $0 | $0 |
| Oct 2021 | $0 | $0 | $0 |
| Sep 2021 | $1.8M | $0 | $1.8M |
| Aug 2021 | $1.9M | $0 | $1.9M |
C000198378 Assets Under Management
Net assets of iShares Evolved U.S. Innovative Healthcare ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2022-07-31 | $36.79M |
| 2022-04-30 | $33.99M |
| 2022-01-31 | $39.81M |
| 2021-10-31 | $42.60M |
| 2021-07-31 | $39.40M |
| 2021-04-30 | $36.32M |
| 2021-01-31 | $35.30M |
| 2020-10-31 | $24.55M |
| 2020-07-31 | $21.02M |
| 2020-04-30 | $12.78M |
| 2020-01-31 | $5.42M |
| 2019-10-31 | $5.16M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.